Neurovascular Compression: New Evidence Reveals Better Pain Management Protocols

Neurovascular compression constitutes a significant etiopathogenic mechanism in various cranial nerve hyperactivity disorders, affecting approximately 5% of patients with unexplained cranial neuropathies. This study examines emerging evidence regarding the management of neurovascular compression syndromes, with particular focus on developments from the past five years. We conducted a comprehensive analysis of recent clinical trials and meta-analyses evaluating both pharmacological and surgical interventions. The pathophysiology involves mechanical distortion of cranial nerves by adjacent vascular structures at the root entry zone, leading to demyelination and ephaptic transmission. High-resolution neuroimaging has substantially altered our understanding of these conditions by enabling precise visualization of previously undetectable vascular conflicts. Our findings indicate that symptoms exist on a severity spectrum, with some patients responding well to pharmacological management alone, challenging the traditional paradigm favoring early surgical intervention. We propose a stratified management algorithm based on symptom severity, imaging findings, and patient characteristics that optimizes outcomes while minimizing unnecessary surgical procedures. Multiple vessel compression, purely venous compression, and previous destructive procedures were associated with less favorable surgical outcomes. This evidence-based approach establishes more standardized pain management protocols for these challenging neurological disorders, while identifying artificial intelligence applications and multimodal pain management as promising future directions